Aduro Clean Technologies Announces Closing of Underwriter’s Over-Allotment Option in Public Offering

Rhea-AI Summary

Aduro Clean Technologies (Nasdaq: ADUR) announced closing of the underwriter's over-allotment option, issuing an additional 260,869 common shares and warrants to purchase 130,434 common shares for total gross proceeds of approximately US$3.0 million. Each whole warrant is exercisable at US$16.00, exercisable immediately and expires three years from issuance.

The company intends to use net proceeds primarily for construction of its Demonstration-Scale Plant, with any remainder for R&D, general corporate purposes and working capital.

Positive

• Raised approximately US$3.0 million from the over-allotment exercise
• Issued 260,869 additional common shares and warrants for 130,434 common shares
• Net proceeds designated for construction of the Demonstration-Scale Plant

Negative

• Immediate warrant exercisability at US$16.00 creates potential near-term dilution
• Share issuance and outstanding warrants increase potential share count, diluting existing holders
• Offering sold only in the United States; no securities were offered or sold to Canadian purchasers

Market Reaction

+4.01% $13.50

15m delay 16 alerts

+4.01% Since News

$13.50 Last Price

$12.86 $14.90 Day Range

+$17M Valuation Impact

$432M Market Cap

1.1x Rel. Volume

Following this news, ADUR has gained 4.01%, reflecting a moderate positive market reaction. Our momentum scanner has triggered 16 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $13.50. This price movement has added approximately $17M to the company's valuation.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

Key Figures

Additional shares issued: 260,869 common shares Additional warrants: 130,434 warrants Gross proceeds: US$3 million +5 more

8 metrics

Additional shares issued 260,869 common shares Issued under over-allotment option in U.S. public offering

Additional warrants 130,434 warrants Accompanying the additional common shares

Gross proceeds US$3 million From full exercise of over-allotment option

Warrant exercise price US$16.00 per share Whole warrants, exercisable immediately, three-year term

Warrant term 3 years Whole warrants expire three years from issuance date

Share price $14.37 Prior close before this announcement

Market cap $485,207,412 Equity value before the over-allotment closing news

52-week range $3.49 – $17.66 Stock trading range over the last 52 weeks

Market Reality Check

Price: $12.98 Vol: Volume 391,323 is below t...

low vol

$12.98 Last Close

Volume Volume 391,323 is below the 20-day average of 646,179 ahead of this financing update. low

Technical Shares trade above the 200-day MA at $11.13, but remain 18.63% below the 52-week high of $17.66.

Peers on Argus

ADUR was down 1.44% while peers were mixed: ARQ -2.41%, PCT -8.83%, FTEK +2.21%,...

2 Up 1 Down

ADUR was down 1.44% while peers were mixed: ARQ -2.41%, PCT -8.83%, FTEK +2.21%, ERII and CECO modestly positive. Scanner names (RAIN, SCWO, ZONE) also showed both up and down moves, supporting a stock-specific reaction.

Previous Offering Reports

5 past events · Latest: Dec 22 (Negative)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 22	Offering closing	Negative	-1.3%	Closed US$20M underwritten offering of shares plus warrants at US$16 exercise.
Dec 19	Offering pricing	Negative	-3.2%	Priced US$20M offering with 1,739,130 shares and half-warrant structure.
Jun 20	Over-allotment closing	Negative	-1.3%	Closed over-allotment, raising US$1.2M via added shares and warrants.
Jun 11	Offering closing	Negative	+6.4%	Closed US$8M underwritten deal; stock rose despite dilutive structure.
Jun 10	Offering pricing	Negative	-19.7%	Priced US$8M offering with share-and-warrant package at US$8.44.

Pattern Detected

Prior offering-related announcements generally saw negative 1-day moves, with one sharp selloff and one notable gain, indicating mixed but often cautious reactions to equity financings.

Recent Company History

Over the past year, Aduro has repeatedly used underwritten offerings and over-allotment options to fund its Demonstration-Scale Plant and related R&D. Events on Jun 10–11, 2025 and Dec 19–22, 2025 priced and closed US$8M and US$20M deals with share-and-warrant structures, typically followed by single-day declines between about 1–3%, plus one larger drop of 19.74% and one 6.44% gain. Today’s over-allotment closing fits this ongoing financing pattern for the build-out strategy.

Historical Comparison

offering

+6.4 %

Average Historical Move

Historical Analysis

In the past year, Aduro issued 5 offering-related updates, averaging a ±6.4% 1-day move, usually skewing negative after new equity financings.

Typical Pattern

Financings progressed from US$8M in June 2025 to US$20M in December 2025, with repeated use of over-allotment options to expand capital for the Demonstration-Scale Plant and R&D.

Market Pulse Summary

This announcement confirms full exercise of the underwriter’s over-allotment option, adding US$3 mil...

Analysis

This announcement confirms full exercise of the underwriter’s over-allotment option, adding US$3 million in gross proceeds via 260,869 additional shares and 130,434 warrants at US$16.00. The funds are earmarked primarily for the Demonstration-Scale Plant, with any remainder for R&D and corporate uses. Historically, similar financings have produced mixed but often cautious price reactions, so investors may focus on execution milestones and capital discipline as key indicators of long-term value.

Key Terms

warrants, exercise price, public offering, Form F-10, +1 more

5 terms

warrants financial

"issued an additional 260,869 common shares and warrants to purchase an additional 130,434 common shares"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

exercise price financial

"Each whole warrant has an exercise price of US$16.00 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

public offering financial

"underwriter’s over-allotment option in connection with the Company’s previously announced underwritten U.S. public offering"

A public offering is when a company sells shares to the general public through the stock market, either by issuing new shares to raise cash or by letting existing owners sell their stakes. Think of it like a business opening its doors to many new owners at once: it can bring in money for growth but also increases the number of shares available, which can change the stock price and dilute existing ownership — key factors investors watch closely.

Form F-10 regulatory

"The Offering was made pursuant to an effective shelf registration statement on Form F-10, as amended"

Form F-10 is a standardized prospectus document filed with Canadian securities regulators when a Canadian company offers shares or other securities to the public. It lays out the company’s business, financial results, management, and risks—like a detailed product label that helps investors compare what they’re buying and understand potential downsides. For investors, the form matters because it provides the core information needed to evaluate the safety, value and terms of a public securities offering.

prospectus supplement regulatory

"A final prospectus supplement with the final terms was filed with the securities regulatory authorities"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. Not financial advice.

LONDON, Ontario, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. ("Aduro" or the "Company") (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that it issued an additional 260,869 common shares and warrants to purchase an additional 130,434 common shares, for total gross proceeds of approximately US$3 million, pursuant to D. Boral Capital LLC’s full exercise of its underwriter’s over-allotment option in connection with the Company’s previously announced underwritten U.S. public offering of common shares and accompanying warrants to purchase common shares (“Offering”). The common shares issued pursuant to the over-allotment option were sold in combination with an accompanying half warrant (with each whole warrant being exercisable into one common share of the Company). Each whole warrant has an exercise price of US$16.00 per share and are exercisable immediately and will expire three years from the date of issuance.

D. Boral Capital LLC acted as lead Underwriter for the Offering. Roth Capital Partners acted as financial advisor for the Offering.

Aduro intends to use the net proceeds from the Offering for expenditures related to the construction of its Demonstration-Scale Plant and the remainder (if any) for ongoing research and development, general corporate purposes and working capital.

The Offering was made pursuant to an effective shelf registration statement on Form F-10, as amended (File No. 333-292023), previously filed with the U.S. Securities and Exchange Commission (“SEC”) on December 15, 2025, which became effective upon filing, and the Company’s Canadian short form base shelf prospectus dated December 15, 2025 (the “Base Shelf Prospectus”). Aduro offered and sold the securities in the United States only. No securities were offered or sold to Canadian purchasers.

The Base Shelf Prospectus relating to the Offering and describing the terms thereof has been filed with the applicable securities commissions in Canada and with the SEC in the United States and is available for free by visiting the Company’s profiles on the SEDAR+ website maintained by the Canadian Securities Administrators at www.sedarplus.ca or the SEC’s website at www.sec.gov, as applicable. A final prospectus supplement with the final terms was filed with the securities regulatory authorities in the Canadian provinces of British Columbia and Ontario and with the SEC. Copies of the final prospectus may be obtained at the SEC's website at www.sec.gov or from D. Boral Capital LLC, Attention: 590 Madison Avenue 39th Floor, New York, NY 10022, or by email at info@dboralcapital.com, or by telephone at +1(212) 970-5150.

Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the Offering. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy any of the Company's securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company's securities in any state or jurisdiction in which such offers, solicitations or sales would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company's Hydrochemolytic™ technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.

For further information, please contact:

Abe Dyck, Head of Corporate Development and Investor Relations
ir@adurocleantech.com
+1 226 784 8889

KCSA Strategic Communications
Jack Perkins, Senior Vice President
aduro@kcsa.com

D. Boral Capital LLC
info@dboralcapital.com
+1 212 970 5150

Forward-Looking Statements
This press release contains forward-looking statements regarding the Company's current expectations. These forward-looking statements include, without limitation, references to the Company's expectations regarding anticipated use of net proceeds from the Offering. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the factors that may result in changes to the Company's anticipated use of proceeds. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's annual information form dated May 20, 2025, which is available on SEDAR+ at www.sedarplus.ca, on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law, including the securities laws of the United States and Canada.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/64e63ba5-a227-425d-86c5-7d955e482c49

FAQ

How many additional shares did Aduro Clean Technologies issue under the over-allotment option (ADUR)?

Aduro issued 260,869 additional common shares under the over-allotment option. According to Aduro Clean Technologies, those shares were sold together with accompanying half warrants as part of the offering.

What were the total gross proceeds from Aduro Clean Technologies' over-allotment exercise (ADUR)?

The over-allotment exercise generated approximately US$3.0 million in gross proceeds. According to Aduro Clean Technologies, proceeds include funds from 260,869 shares and related warrants sold to the underwriter.

What are the terms of the warrants issued in Aduro Clean Technologies' over-allotment (ADUR)?

Each whole warrant has an exercise price of US$16.00, is exercisable immediately, and expires three years from issuance. According to Aduro Clean Technologies, half warrants were paired with the additional shares sold.

How will Aduro Clean Technologies use the net proceeds from the offering (ADUR)?

The company intends to use net proceeds primarily for construction of its Demonstration-Scale Plant. According to Aduro Clean Technologies, any remaining funds will support R&D, general corporate purposes and working capital.

Which underwriter exercised the over-allotment option for Aduro Clean Technologies (ADUR)?

D. Boral Capital acted as lead underwriter and fully exercised the over-allotment option. According to Aduro Clean Technologies, D. Boral Capital purchased the additional shares and warrants.

Were Aduro Clean Technologies securities offered to Canadian investors in this offering (ADUR)?

No; the securities were offered and sold in the United States only and no securities were offered or sold to Canadian purchasers. According to Aduro Clean Technologies, the offering complied with the filed prospectus and regulatory filings.